Rapid risk assessment: Potential resurgence of highly pathogenic H5N1 avian influenza
The increased reports of A(H5N1) outbreaks in poultry and wild bird populations, and the emergence of a further evolved lineage of the virus in poultry in some countries, do not change the current assessment of the risk to human health.
Surveillance and disease data for zoonotic influenza
Surveillance reports and data: Disease data from ECDC Surveillance Atlas, Annual Epidemiological Reports and Surveillance reports.
No new human infections with A/H5N1 in Turkey but national measures and international support continue.
Communicable disease threats report, 16 July - 23 July, week 29
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9 July - 15 July 2017 and includes updates on measles, influenza A(H7N9), poliomyelitis, West Nile fever, rubella, salmonella and cyclosporiasis.
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
Influenza virus characterisation, Summary Europe, June 2017
In the course of the 2016–2017 influenza season, nearly 146 000 influenza detections across the EU/EAA region have been reported.